{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:29:26Z","timestamp":1770740966553,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jdcr.2023.06.016","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T21:08:02Z","timestamp":1687295282000},"page":"152-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Optimizing the pharmacokinetics of sonidegib in small bowel syndrome and advanced basal cell carcinoma: Our solution"],"prefix":"10.1016","volume":"38","author":[{"given":"Hailey","family":"Grubbs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Strasswimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdcr.2023.06.016_bib1","unstructured":"ODOMZO\u00ae (sonidegib) capsules. Full prescribing information. Sun Pharmaceutical Industries, Inc.; 2019"},{"key":"10.1016\/j.jdcr.2023.06.016_bib2","unstructured":"Erivedge\u00ae (vismodegib) capsules. Full prescribing information. Genentech, Inc.; 2020"},{"key":"10.1016\/j.jdcr.2023.06.016_bib3","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2147\/OTT.S130910","article-title":"Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas","volume":"10","author":"Jain","year":"2017","journal-title":"OncoTargets Ther"},{"issue":"1-2","key":"10.1016\/j.jdcr.2023.06.016_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000509156","article-title":"High-risk recurrence basal cell carcinoma: focus on Hedgehog pathway inhibitors and review of the literature","volume":"65","author":"Campione","year":"2020","journal-title":"Chemotherapy"},{"issue":"19","key":"10.1016\/j.jdcr.2023.06.016_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910725","article-title":"Patidegib in dermatology: a current review","volume":"22","author":"Cosio","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.jdcr.2023.06.016_bib6","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jdcr.2016.06.010","article-title":"Spontaneous resolution of advanced basal cell carcinoma after short-pulse treatment with Hedgehog pathway inhibitor","volume":"2","author":"Jacobsen","year":"2016","journal-title":"JAAD Case Rep"},{"issue":"6","key":"10.1016\/j.jdcr.2023.06.016_bib7","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jaad.2015.12.035","article-title":"Four-year experience with vismodegib Hedgehog inhibitor therapy","volume":"74","author":"Simone","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.jdcr.2023.06.016_bib8","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1001\/jamadermatol.2016.0780","article-title":"Hedgehog pathway inhibitor therapy for locally advanced and metastatic basal cell carcinoma: a systematic review and pooled analysis of interventional studies","volume":"152","author":"Jacobsen","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.jdcr.2023.06.016_bib9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/cpdd.416","article-title":"To take or not to take with meals? Unraveling issues related to food effects labeling for oral antineoplastic drugs","volume":"7","author":"Deng","year":"2018","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"6","key":"10.1016\/j.jdcr.2023.06.016_bib10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3390\/biomedicines8060156","article-title":"Arsenic trioxide, itraconazole, all-trans retinoic acid and nicotinamide: a proof of concept for combined treatments with Hedgehog inhibitors in advanced basal cell carcinoma","volume":"8","author":"Cosio","year":"2020","journal-title":"Biomedicines"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512623002138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512623002138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:25:23Z","timestamp":1762475123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512623002138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":10,"alternative-id":["S2352512623002138"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2023.06.016","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing the pharmacokinetics of sonidegib in small bowel syndrome and advanced basal cell carcinoma: Our solution","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2023.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}